Nationalität
UK

Geburtsjahr
1962

Leiter Roche Pharma Research & Early Development (pRED) und Mitglied der Erweiterten Konzernleitung (a.i.)

  • Universität Bristol, Bristol, UK, MB. ChB (1989)

  • Universität Bristol, Bristol, UK, PhD (1999)

  • Mitglied des Royal College of Physicians

  • Mitglied des Royal College of Paediatrics and Child Health

1989-1994
Bristol Royal Hospital for Sick Children, UK
Physician and Registrar

1995
University of Bristol, UK
Clinical Research Fellow

1999
Bristol Royal Hospital for Sick Children, UK
Senior Registrar

1999
Eli Lilly, UK
Medical Fellow

2006
Roche Welwyn, UK
Translational Medicine Leader

2007
Roche Welwyn, UK
Acting Global Head, Clinical Research & Exploratory Development Oncology

2008
Roche Welwyn, UK
European Head of Clinical Research & Exploratory Development Oncology

2010
Roche Nutley, USA
Global Head DTA Oncology

2011
Roche Nutley, USA
Global Head DTA Oncology and Head of Large Molecule Research

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

you go to an external page